Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br. 2012 Feb; 94(2):257-64.

View in: PubMed

subject areas

Administration, Oral
Aged
Anticoagulants
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Double-Blind Method
Drug Administration Schedule
Enoxaparin
Female
Fibrinolytic Agents
Humans
Injections, Subcutaneous
Male
Middle Aged
Perioperative Care
Postoperative Hemorrhage
Pyrazoles
Pyridones
Randomized Controlled Trials as Topic
Treatment Outcome
Venous Thromboembolism

authors with profiles

Gary E Raskob